In 2024, Daniel T. Scavilla earned $1.25M in total compensation at DENTSPLY SIRONA, primarily from $1.02M salary. Most recently sold 100,000 shares in Jul 2021. Currently holds stock worth $5.47M.
Compensation History
Annual executive compensation data for Daniel T. Scavilla, including salary, bonuses, and stock awards.
Year
2024
Total Compensation
$1.25M
Salary
$1.02M
Bonus
$0.00
Other
$230.00K
Salary
$1.02MBoard Justification
The Compensation & Human Capital Committee’s compensation philosophy, when determining NEO compensation at the beginning of 2024, was to provide a compensation package designed to generally satisfy and balance the following principal objectives to: align executive compensation with corporate performance and stockholder interests, tie components of executives’ compensation to the Company’s performance, both attract and retain executives and key contributors, ensure pay parity, balance risk and reward, and targeting total direct compensation at the 50th percentile of compensation paid by the Company’s peers for comparable executive roles.
Bonus
$0.00Board Justification
N/A
Other Compensation
$230.00KBoard Justification
Includes 401(k) Savings & ESOP Contributions and Commuting
Restricted Stock
Board Justification
N/A
Performance Metrics
Organic net sales and adjusted EBITDA margin percentage were chosen by the Compensation & Human Capital Committee as the financial metrics for baseline funding level of the 2024 Annual Incentive Plan (“AIP”) in order to reflect topline focus, balanced with an emphasis on restructuring and expense reduction. The Compensation & Human Capital Committee chose strategic objective modifiers, including DS Core total registrations, U.S. Implant growth, U.S. DSO growth, progress status of foundational initiatives (ERP, Quality, SKU, Supply Chain Transformation) and placement of IOS units, which could increase or reduce 2024 AIP payout by up to +/- 20% in the aggregate.
Daniel T. Scavilla
CEO of DENTSPLY SIRONA
Education
B.S. from LaSalle University, M.B.A. from Temple University
Field of Expertise
Finance & Banking - Finance
Sector of Economy
Healthcare
Born
January 1, 1965 - 60 years ago
CEO of DENTSPLY SIRONA for
0 years 4 months (Aug 2025 - Present)
Previous Experience
Unknown
Other DENTSPLY SIRONA CEOs
Holdings
Track Daniel T. Scavilla's stock holdings and portfolio value over time.
Total Stock Sold
$18.33M
$18.33M
300,000 GMED shares
What if they kept their stock?
If Daniel T. Scavilla didn't sell their stock, today they would have:
Extra GMED300,000 shares worth $27.33M.
This is 49.13% and $9.00M more than what they got when they sold the stock.
Insider Trading
Daniel T. Scavilla's recent stock transactions, purchases, and sales filed with the SEC.
$7.87M
GMED at $78.69/share
Jul 2, 2021
Sale
$5.51M
GMED at $55.09/share
May 21, 2020
Sale
$5.00M
GMED at $50.00/share
Apr 9, 2018
Sale
Rivals
Compare Daniel T. Scavilla with competitor CEOs and industry peers.